




版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
DilatedCardiomyopathy
DCMGUJunDept.of
CardiovascularMedicine
Case
A36yearoldmancomestoyourofficecomplainingofthreemonthsofprogressivefatigueanddyspneaonexertion.Severaltimesinthepastmonthhehasawakenedfromsleepwithseverebreathlessnessandfeltaneedtositupinordertobreath.Hedeniesanychestpain.Hehasnopastmedicalhistoryofheartdisease,hypertensionordiabetes.Hisfamilyhistoryisnegativeforheartdisease.Hedoesnotsmokeanddrinksalcoholonlyrarely.Hetakesnomedications.PhysicalExaminationBP105/70mmHg,P98regularLungs:rales.Heart:Enlargedheartborder. S1diminishedintensity,S2normal,S3ispresent. 2/6systolicmurmurattheapex.Abdomen:Liverisenlargedandslightlytender topressure.Extremities:Mildedemaofbothfeet.DilatedCardiomyopathy,DCMDefinitionHeartmuscledisorderEnlargedleftventricleorbothventriclesImpairedsystolic
pumpfunctionOftenwithmanifestationofheartfailureorarrhythmiaEpidemiologyAnnualincidence:5-10patientspermillionMale-femaleratio:2.5:1Averageageofincidence:40HigherincidenceinthedevelopingcountriesAnnualmortalityrate:25%-45%EtiologyNotclearFamilial/genetic(20%)
ViralinfectiousagentsandautoimmuneAcuteviral
myocarditis
canprogresstochronicdilatedcardiomyopathyChronichormonaldisordersUseofcertainsubstances,especiallyalcohol,cocaine,antidepressants,andchemotherapydrugsPathologyGrossexamination:
ThinnedventricularwallsEnlargedventriclesFibrinandscarMuralthrombus
Normalvalvesandcoronaryarteries
DCMNormalMicroscopicexamination:
Myocardialcellmaybehypertrophy,
denaturation,fibrosisornecrosis.PathologyPathophysiologyPumplessbloodforthebody'sneeds
HeartfailureMyocardialchangesinvolveconductionsystemArrhythmiaMuralthrombusfalloffEmbolismClinicalManifestation
Symptoms:
NosymptomintheearlystageFatigue,dyspnea,orthopnea
Anorexia,edemaPalpitation,arrhythmia(Af,VT)Embolism(brain,lung,lowerextremity)Suddendeath(VT,embolism,bradycardia)ClinicalManifestation
Signs:
Cardiacdullnessextendstoleftanddownwards
Rales,pleuraleffusionJugularvenousdistention,hepatomegaly,edemaGalloprhythm,S3,S4Systolicmurmurovertheapexarea(mitralinsufficiency)AccessoryExaminationChestX-rayEnlargementoftheheartSignsofpulmonarycongestionAccessoryExaminationECG
AtrialfibrillationConductionblockST-TchangesLow-voltageQRSPathologicQwaveVentricularprematureortachycardiaAccessoryExaminationAccessoryExaminationEchocardiographyDilatedleftventricleorbothventriclesRelativemitral/tricuspidinsufficiencyduetodilatedleft/rightventricleVentricularwallsnotthickPoorlycontractileleftventricleEF<50%AccessoryExaminationCoronaryangiography:UsuallynormalCardiacbiopsy:Fibrosisormyocardialcelluarhypertrophy,denaturationornecrosisExcludeotherheartdiseases
DilatedheartArrhythmiaHeartfailure
Echo:dilated&poorlycontractileventricleCoronary/Rheu-matic/HypertensiveheartdiseaseDiagnosisSpecificcardiomyopathy
EXCLUDEDiagnosisDCMIschemiccardiomyopathyICMAgeHistoryOfteninmiddleage,<40yearsoldOfteninoldage,>40yearsoldMyocarditis,Nohistoryofangina
RiskfactorsofCHD,historyofanginaormyocardialinfarctionDifferentialdiagnosisDCMICMEchoOftenfourchambersdilated,theweakmovementofwholeheart,muralthrombusinsomepatientsOftenonlyleftventricledilated,segmentalmovementabnormality,ventricularaneurysminsomepatients
Angio-graphyNormalMultivesseldiseaseDifferentialdiagnosisTreatmentGeneraltreatmentDecreasedactivityandbedrestSaltrestrictionStopalcoholNutritionalsupportTreatmentTreatmentofheartfailureDigitalisDiureticsVasodilatorsACEI(angiotensinconvertingenzymeinhibitors)ARB(angiotensin
receptorblockers)TreatmentAntiarrhythmictreatmentBetablockers(startwithlow-dose,increasedosegradually)Amiodarone
PacemakerimplantationICD
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 【正版授權(quán)】 IEC TR 63502:2024 EN Guidelines for parameters measurement of HVDC transmission line
- 2025-2030年中國(guó)鉛鋅行業(yè)十三五投資分析及發(fā)展風(fēng)險(xiǎn)評(píng)估報(bào)告
- 2025-2030年中國(guó)針織面料市場(chǎng)運(yùn)營(yíng)狀況與發(fā)展?jié)摿Ψ治鰣?bào)告
- 2025-2030年中國(guó)酵母核糖核酸市場(chǎng)運(yùn)行趨勢(shì)及投資戰(zhàn)略研究報(bào)告
- 2025-2030年中國(guó)速溶固體飲料市場(chǎng)發(fā)展趨勢(shì)及前景調(diào)研分析報(bào)告
- 2025-2030年中國(guó)豆腐市場(chǎng)運(yùn)行狀況及發(fā)展趨勢(shì)分析報(bào)告
- 2025-2030年中國(guó)血液透析機(jī)市場(chǎng)運(yùn)營(yíng)現(xiàn)狀及發(fā)展前景規(guī)劃分析報(bào)告
- 2025-2030年中國(guó)脫咖啡因綠茶市場(chǎng)發(fā)展策略規(guī)劃分析報(bào)告
- 2025-2030年中國(guó)美白護(hù)膚市場(chǎng)運(yùn)行狀況及投資戰(zhàn)略研究報(bào)告
- 2025年上海市建筑安全員-A證考試題庫(kù)及答案
- 農(nóng)藥經(jīng)營(yíng)管理知識(shí)培訓(xùn)專家講座
- 《自主創(chuàng)新對(duì)于鋼結(jié)構(gòu)發(fā)展的重要性》2400字
- 食品采購(gòu)與進(jìn)貨臺(tái)賬
- GB/T 24353-2022風(fēng)險(xiǎn)管理指南
- GB/T 6284-2006化工產(chǎn)品中水分測(cè)定的通用方法干燥減量法
- GB/T 3003-2017耐火纖維及制品
- GB/T 22080-2016信息技術(shù)安全技術(shù)信息安全管理體系要求
- GB/T 13915-2013沖壓件角度公差
- 制藥工程導(dǎo)論課件
- 瑜伽師地論(完美排版全一百卷)
- 槳聲燈影里的秦淮河1-課件
評(píng)論
0/150
提交評(píng)論